PHARMACEUTICAL COMPOSITION INCLUDING MELANINS AS ANTIBODY FOR THERAPEUTIC AGENT

PROBLEM TO BE SOLVED: To treat a degenerative disease of nervous systems by administeving an active substance for increasing the concentration of a melanin, a melanin precursor, a melanin derivative, a melanin variant and a melanin analog contained in the nervous systems affected. SOLUTION: The trea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BERLINER DAVID L, MCGEE DAVID R, ERWIN ROBERT L
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To treat a degenerative disease of nervous systems by administeving an active substance for increasing the concentration of a melanin, a melanin precursor, a melanin derivative, a melanin variant and a melanin analog contained in the nervous systems affected. SOLUTION: The treatment is carried out by using a pharmaceutical composition for therapy for the mammals in which a therapeutic agent and an antibody for the therapeutic agent are contained and the antibody consists of a melanin polymer, a melanin variant, a melanin derivative or a melanin analog.